Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
12 hedge funds and large institutions have $7.6M invested in Intellipharmaceuticals International Inc. in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
20% more funds holding
Funds holding: 10 → 12 (+2)
10% more capital invested
Capital invested by funds: $6.92M → $7.6M (+$675K)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$106K |
| 2 |
AIG
American International Group
New York
|
+$7.86K |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$1.63K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$550 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$402K |
| 2 |
FNYS
First New York Securities
New York
|
-$296K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
1
Broadfin Capital
New York
| $3.44M | -$402K | -20,452 | -10% |
|
|
TCM
2
Tekla Capital Management
Boston,
Massachusetts
| $3.4M | – | – | – |
|
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $628K | +$106K | +5,419 | +20% |
|
4
Neuberger Berman Group
New York
| $57K | – | – | – |
|
|
VKH
5
Virtu KCG Holdings
New York
| $33K | +$33K | +1,681 | New |
|
|
FNYS
6
First New York Securities
New York
| $26K | -$296K | -15,072 | -92% |
|
|
AIG
7
American International Group
New York
| $7.84K | +$7.86K | +400 | New |
|
|
8
AllianceBernstein
Nashville,
Tennessee
| $2K | +$1.63K | +83 | New |
|
|
9
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | +$550 | +28 | +2,800% |
|
IPCI Hedge Fund Activity: Q3 2013 in Review
12 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q3 2013, worth a combined $7.6M — up 9.7% from $6.92M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IPCI positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $106K. The largest seller was Broadfin Capital, cutting an estimated $402K.
- 12 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q3 2013, up from 10 in Q2 2013.
- Funds reported $7.6M of Intellipharmaceuticals International Inc. stock for Q3 2013, up 9.7% quarter-over-quarter.
- 3 funds opened new Intellipharmaceuticals International Inc. positions in Q3 2013 and 1 closed out, a net change of +2 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q3 2013 was Deutsche Bank, an estimated $106K added.
- The largest Intellipharmaceuticals International Inc. seller in Q3 2013 was Broadfin Capital, an estimated $402K sold.
Based on aggregated 13F filings for Q3 2013.